DRKS00025228招募中未知
Reducing complexity of drug treatment in patients with polypharmacy while taking patient preferences into account in public pharmacies
Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik0 个研究点目标入组 162 人开始时间: 2021年5月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 162
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1) Use of more than 5 drugs.
- •2) Regular use of the drugs
- •3) Written informed consent
排除标准
- •1) Insufficient proficiency in German
- •2) Cognitive and physical impairments that make it impossible to conduct the study
- •3) Absence or withdrawal of informed consent
研究者
相似试验
尚未招募
不适用
Intervenções Farmacêuticas sobre o tratamento medicamentoso dos idosos com Doença de Risco CardiovascularPolypharmacyE02.319RBR-8dvw5zpFundação Universidade Federal de Sergipe
进行中（未招募）
不适用
Minimising the Functional Burden of Medications in Older Inpatients: Implementation of the Drug Burden Indexadverse effectsfrailtyfallshigh risk medicationsACTRN12617000765325Royal North Shore Hospital400
已完成
不适用
Reduction of potentially inappropriate medication in the elderypotentially inappropriate medication in the elderly (no specific disease or condition necessary for study inclucion)DRKS00003610Ruhr-Universität Bochum1,275
进行中（未招募）
不适用
SImplification of Medications Prescribed to Long tErm care Residents (SIMPLER)polypharmacymedication incidentscognitive impairmentfallshospitalisationfrailtyPublic Health - Health service researchNeurological - DementiasdementiaACTRN12617001060336Centre for Medicine Use and Safety, Monash University194
进行中（未招募）
1 期
Reduction in the number of chemotherapy cycles in combination with Pembrolizumab in first-line treatment of PD-L1-positive recurrent or metastatic head and neck squamous cell carcinomasFirst-line treatment of PD-L1-positive recurrent or metastatic head and neck squamous cell carcinomasMedDRA version: 27.0Level: LLTClassification code: 10090001Term: Squamous cell carcinoma of head and neck recurrent Class: 100000004864MedDRA version: 27.0Level: LLTClassification code: 10082179Term: Squamous cell carcinoma of head and neck metastatic Class: 10029104CTIS2024-514875-16-00Oncopole Claudius Regaud93